Mode
Text Size
Log in / Sign up
N/A N=47 Randomized Treatment

HealthCall-S: A Pilot Study Targeting Concurrent Non-injection Drug Use and Alcohol in HIV Primary Care Clinics

Alcohol or Other Drugs Use

Enrolled (actual)
47
Serious AEs
6.4%
Results posted
Jun 2019
Primary outcome: Primary: Mean Number of Days Used Primary Drug (NumDU) — 8.5; 5.0 days

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
HealthCall+Motivational Interviewing (Behavioral); Motivational Interviewing (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Research Foundation for Mental Hygiene, Inc.
Primary completion
Jan 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Mean Number of Days Used Primary Drug (NumDU)
8.5; 5.0
PRIMARY
Mean Dollar Amount Spent Per Day on Primary Drug (QuantU)
14.6; 7.1
PRIMARY
Mean Number of Drinking Days (NumDD)
8.1; 7.0
PRIMARY
Mean Number of Drinks Per Day (QuantDD)
1.3; .9

Summary

This pilot study goal is to compare two different treatments to help HIV positive patients reduce their concurrent drinking and non-injection drug use.

Eligibility Criteria

Inclusion Criteria

Age 18 and older; 2. During the prior 30 days, > 4 days of non-injection of cocaine, methamphetamine or heroin, one of which is identified by the patient as his/her primary drug During prior 30 days, > 1 day of binge drinking (>4 drinks on one occasion); Completion of medically supervised detoxification if such detoxification is required; HIV Positive ; Able to give informed consent

Exclusion Criteria

Patient is currently psychotic, suicidal, or homicidal. Patient has injected any drug in the last 6 months Patient has definite plans to leave the greater New York metropolitan area within the study period.

Patient has gross cognitive/psychomotor impairment as evidenced on the Halstead-Reitan Trails (A+B) Patient does not speak English or Spanish Patient has a hearing and/or vision impairment that precludes smartphone use.

-

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02294318). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search